T. Rowe Price Blue Chip Growth ETF

September's Top Articles for ETFDB Touch on AI, Interest Rates

September's top five articles were drawn from across the entire spectrum of the ETF Database content hubs, touching on a variety of topics that are dominating the autumn news cycle. However, the most read article of the month touched on the hottest subject of 2026 — artificial intelligence (AI).

Beyond AI Stocks: As Markets Broaden, Look to Active ETFs

AI headlines are getting spooky, but what about AI stocks? The hyperscalers and megacap tech firms make outsized contributions to market movement.

T. Rowe Price: Which AI Stocks Have Growth Built to Last?

Not every AI stock riding this year's rally has growth that will last, according to T. Rowe Price portfolio manager Paul Greene.

Cwm LLC Sells 48,761 Shares of T. Rowe Price Blue Chip Growth ETF $TCHP

Cwm LLC lessened its position in shares of T. Rowe Price Blue Chip Growth ETF (NYSEARCA:TCHP) by 49.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,658 shares of the company's stock after selling 48,761 shares

Armstrong Fleming & Moore Inc Has $25.26 Million Stock Position in T. Rowe Price Blue Chip Growth ETF $TCHP

Advisors Seek Active ETFs as Market Concentration Rises

Financial advisors are turning to active ETFs as a solution to navigating concentrated markets. Recent survey data reveals that fundamental research and strong performance top their priority lists.

Report: Active ETFs Topped $2 Trillion in Global AUM in January

Active ETFs have continued their ascent to start 2026. The category, which has seen accelerated launches and flows in recent years, surpassed a major milestone in January.

TCHP ETF: Ongoing Underperformance From This High-Fee Fund

The T. Rowe Price Blue Chip Growth ETF remains a Hold due to persistent underperformance versus the S&P 500 and elevated fees. TCHP's concentrated tech exposure initially drove outperformance, but recent returns have mirrored SPY, eroding its active management thesis. Portfolio overweighting in NVDA, MSFT, AAPL, and GOOG (~43%) has not offset underweights in outperforming sectors like Healthcare and Industrials.